Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep Apnea
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00307944|
Recruitment Status : Completed
First Posted : March 28, 2006
Last Update Posted : December 12, 2007
|Condition or disease||Intervention/treatment||Phase|
|Acid Reflux Disease Obstructive Sleep Apnea||Drug: Pantoprazole||Phase 4|
Half of the patients enrolled in the study will begin the study taking Pantoprazole. The other half will begin the study taking a placebo (sugar pill). There is an equal chance of being placed in either group.
After two weeks, the patients will stop taking their first batch of medication to allow it to completely leave their bodies. Then the patients will begin taking the other medication so that by the end of the study, each patient will have been treated with pantoprazole for two weeks and placebo for two weeks.
At the end of each two weeks, patients will be asked to complete questionnaires regarding their daytime sleepiness and reflux symptoms. Patients will also complete reaction time testing as a measure of daytime sleepiness.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||68 participants|
|Intervention Model:||Crossover Assignment|
|Official Title:||Randomized, Placebo-Controlled Trial of Pantoprazole for Sleepiness Associated With Acid Reflux and Obstructive Sleep Disordered Breathing|
|Study Start Date :||August 2004|
|Study Completion Date :||August 2006|
- Difference between treatment groups with regard to change in sleepiness score (ESS)
- Difference between treatment groups with regard to change in reaction time testing.
- Difference between treatment groups with regard to change in total reflux symptom scores.
- Difference between treatment groups with regard to change in sleep related QOL (FOSQ).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00307944
|United States, Ohio|
|University Ear, Nose and Throat Specialists|
|Cincinnati, Ohio, United States, 45267-0528|
|Principal Investigator:||David L Steward, MD||University Ear, Nose and Throat Specialists|